NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jonathan J Beitler
Emory University - Atlanta / United States
Medical and Health Sciences / Otorhinolaryngology
AD Scientific Index ID: 1361915
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jonathan J Beitler's MOST POPULAR ARTICLES
1-)
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01)JS Cooper, MD Guo, A Herskovic, JS Macdonald, JA Martenson Jr, ...Jama 281 (17), 1623-1627, 199923801999
2-)
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or …JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ...The lancet oncology 16 (2), 187-199, 201517182015
3-)
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trialML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ...The Lancet 393 (10166), 40-50, 20198272019
4-)
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522KK Ang, Q Zhang, DI Rosenthal, PF Nguyen-Tan, EJ Sherman, RS Weber, ...Journal of clinical oncology 32 (27), 2940-2950, 20148762014
5-)
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck …R Haddad, A O\'Neill, G Rabinowits, R Tishler, F Khuri, D Adkins, J Clark, ...The Lancet Oncology 14 (3), 257-264, 20137972013
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept